Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multi-Center Study to Evaluate Cardiovascular Outcomes With ITCA 650 in Patients Treated With Standard of Care for Type 2 Diabetes

NCT01455896 is registered in ClinicalTrials.gov with Intarcia Therapeutics as lead sponsor.

NCT NCT01455896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01455896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multi-Center Study to Evaluate Cardiovascular Outcomes With ITCA 650 in Patients Treated With Standard of Care for Type 2 Diabetes
Lead sponsor
Intarcia Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2013
Completion date
March 31, 2016
Enrollment
4,156 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes